G1 Therapeutics Investor Relations Material
Latest events
Study Update
G1 Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from G1 Therapeutics Inc
Access all reports
G1 Therapeutics Inc is a biopharmaceutical company developing therapies for the treatment of cancer. The company focuses on small-molecule drugs designed to preserve bone marrow and enhance the effectiveness of chemotherapy. Its operations span research, clinical development, and regulatory affairs. The company is headquartered in Research Triangle Park, North Carolina, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
GTHX
Country
🇺🇸 United States